Company profile
Breakpoint Therapeutics company profile
Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. Their mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Business identity
- Website
- https://www.breakpointtx.com
- Contact email
- [email protected]
- Phone number
- +49 40 56081 180
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Hespe, Lower Saxony, Germany
- Postal code
- 22419
- Country code
- DE
- Continent
- Europe